After two years in the doldrums, the stock is soaring.
Sanofi believes in Novavax's vaccine strengths...
Moderna's shares slipped after the company announced the delay.
Patience often pays off in the equity markets.
CAMBRIDGE, MA / ACCESSWIRE / May 13, 2024 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences:
This team-up is more than a PR stunt, but it might not be revolutionary.
The S&P 500 Index ($SPX ) (SPY ) Friday rose +0.16%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +0.32%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.26%. US stocks on Friday gained support...
The S&P 500 Index ($SPX ) (SPY ) today is up +0.05%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.20%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.06%. US stock indexes today are slightly...
U.S. FDA has informed Moderna that due to administrative constraints, the agency will not complete its review of mRNA-1345 by the PDUFA date of May 12, 2024
The COVID-19 pandemic thrust this company's science -- and its stock -- into the spotlight.